Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Sections
Personal tools
Log in
 
You are here: Home › Collaborative Groups › Prostate and Urologic Cancers Research Group › Completed validation of %[-2]proPSA to improve PSA-based detection of prostate cancer; IVD pending FDA review

Completed validation of %[-2]proPSA to improve PSA-based detection of prostate cancer; IVD pending FDA review

Announcement